Aseptic/Sterile Processing

Aug 18, 2017
By Pharmaceutical Technology Editors
FDA sent a warning letter to Maple Rose Enterprises, Inc., dba Pencol Compounding Pharmacy, citing the company for violations of sterile manufacturing practices.
Jul 25, 2017
By Pharmaceutical Technology Editors
FDA sent a warning letter to Sage Products, Inc. regarding CGMP failures involving test methods, sampling, and sterilization procedures.
Jul 18, 2017
By Pharmaceutical Technology Editors
The agency cited the Italian company for aseptic processing failures.
Jul 02, 2017
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Advancements in cell culture and protein technology have opened the door for new therapies.
Jul 02, 2017
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Pharma company consolidation and outsourcing led to a de-emphasis of manufacturing and reduced investment in new technologies and facilities.
Jul 02, 2017
Pharmaceutical Technology
Oral solid-dosage and parenteral drug manufacturing equipment and systems have made great strides in safety and efficiency.
Jun 26, 2017
By Pharmaceutical Technology Editors
Fagron Sterile Services has voluntarily recalled three lots of Succinylcholine Chloride 20mg/mL 5mL syringe to the hospital/clinic level.
Jun 21, 2017
Equipment and Processing Report
The need for flexibility and higher quality are driving advances in parenteral manufacturing and fill/finish equipment.
Jun 19, 2017
By Pharmaceutical Technology Editors
The company has voluntarily recalled Clindamycin Injection USP ADD-Vantage Vials to the hospital/retail level because of a lack of sterility assurance.
Jun 14, 2017
By Pharmaceutical Technology Editors
FDA sent a warning letter to drug compounder DCA, Inc. dba Beacon Prescriptions for failing to ensure sanitary conditions.
native1_300x100
lorem ipsum